BioRescue
BioRescue is an international, publicly funded research consortium developing advanced assisted reproduction and stem cell technologies to save the Northern White Rhino from extinction, producing embryos for transfer into surrogate southern white rhino mothers.
- Company typePrivate
- Founded2019
- HeadquartersBerlin, Germany
- Headcount—
- GTM typeB2B
- OfferingServices
What BioRescue does
BioRescue is an international, publicly funded research consortium initiated in 2019 to prevent the extinction of the Northern White Rhino (Ceratotherium simum cottoni), a critically endangered subspecies reduced to two surviving females (Najin and Fatu), both unable to carry pregnancies naturally. The project is led by the Leibniz Institute for Zoo and Wildlife Research (Leibniz-IZW) in Berlin, with the legal hosting entity being the non-profit Forschungsverbund Berlin e.V., and is primarily funded by the German Federal Ministry of Education and Research (BMBF/BMFTR) under grant 01LC1902A, supplemented by private foundations and public donations.
The consortium's core technology is Advanced Assisted Reproduction Technologies (aART) — specifically ovum pick-up (OPU), in-vitro maturation, piezo-intracytoplasmatic sperm injection (ICSI) fertilisation, embryo culture to blastocyst, cryopreservation, and embryo transfer into surrogate southern white rhino mothers — combined with Stem Cell Associated Techniques (SCAT) for generating functional oocytes and sperm from pluripotent stem cells to expand limited genetic diversity. BioRescue has produced 38 pure NWR embryos from 21 OPUs in female Fatu (2019–2025), with an additional embryo announced April 2026, and achieved the world's first confirmed 70-day rhinoceros pregnancy in September 2023. Three subsequent pure-NWR embryo transfers (July 2024, December 2024, May 2025) have not yet produced a live birth. The consortium also developed ETHAS, a systematic ethical assessment tool extended in 2024 to cover genome resource banking.
The consortium's operating model is non-commercial: it does not sell products or services and has no disclosed revenue. It operates through a network of core scientific partners (Leibniz-IZW, Max Delbrück Center, Avantea, University of Padua, University of Osaka, Kyushu University, Safari Park Dvůr Králové) and on-the-ground execution partners in Kenya (Ol Pejeta Conservancy, Kenya Wildlife Service, Wildlife Research and Training Institute), under regulatory oversight from Kenyan and German authorities. Outputs are disseminated through peer-reviewed publications, press, documentary media, and donation channels.
BioRescue firmographics
Firmographics- Name
- BioRescue
- Legal name
- Forschungsverbund Berlin e.V.
- Website
- https://biorescue.org
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Short description
- BioRescue is an international, publicly funded research consortium developing advanced assisted reproduction and stem cell technologies to save the Northern White Rhino from extinction, producing embryos for transfer into surrogate southern white rhino mothers.
- Ownership category
- akta.pro rank
BioRescue industry classification
Industry- Product category
- Wildlife Conservation Biotechnology
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Biological Product (except Diagnostic) Manufacturing (325414), Support Activities for Animal Production (11521)
- SIC
- Services-Commercial Physical & Biological Research (8731), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Cell & Gene Therapy for Veterinary Regeneration (HLAMANAD)
- akta.pro secondary industries
- Cryopreservation, Biobanking & Cell Banking (Cord/Adipose/MSC) (HLAMANAJ), Clinical Research, Trials & Translational Services (Veterinary Regenerative) (HLAMANAL), Cryopreservation & Germplasm Banking (Semen/Embryos/Oocytes) (AFAEAJAH)
Keywords
Where BioRescue is headquartered
LocationHeadquarters
- HQ city
- Berlin
- HQ country
- Germany
- HQ region
- Europe
Offices8 records
Markets served
BioRescue business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Supply Chain, Others
Distribution channels1 record
Marketing channels6 records
BioRescue product offering
Product offeringCore offering
BioRescue is a research consortium that develops and deploys advanced assisted reproduction technologies (aART) — including ovum pick-up, in-vitro fertilization, intra-cytoplasmic sperm injection, and embryo transfer — together with stem cell-associated techniques (SCAT) such as PGCLC induction, to generate viable Northern White Rhino embryos and eventually restore the subspecies. Its outputs include embryo production for transfer into surrogate southern white rhinos, a genome resource bank of cryopreserved biological material, and ethical frameworks (ETHAS) for guiding conservation biobanking decisions.
Product overview
BioRescue is a research consortium (not a commercial product company) developing advanced reproductive technologies for wildlife conservation. The core offering consists of Advanced Assisted Reproduction Technologies (aART) including ovum pick-up (OPU), in-vitro fertilisation (IVF), embryo transfer, and cryopreservation services for producing northern white rhino embryos. These are complemented by Stem Cell Associated Techniques (SCAT) for generating artificial gametes from stem cells, the ETHAS ethical assessment tool for evaluating procedures, and biobanking services for cryogenic storage of genetic material. All technologies are focused exclusively on saving the critically endangered northern white rhino from extinction through surrogate pregnancy using southern white rhino mothers.
Differentiator
Problem solved
Functional benefit
Products and services
- Advanced Assisted Reproduction Technologies (aART) Program for Northern White Rhino An integrated program of advanced assisted reproduction technologies (aART) — including ovum pick-up (OPU), in-vitro fertilization (IVF), intra-cytoplasmic sperm injection (ICSI), and embryo transfer — applied to northern white rhinoceros to generate embryos from the remaining genetic stock. Delivered to wildlife authorities, conservation stakeholders, and partner institutions for species recovery deployment.
- Northern White Rhino Embryo Production Service Production of viable northern white rhino embryos through the combined aART (gamete recovery, IVF/ICSI) and SCAT (stem cell-derived gametes) pipelines, delivered to wildlife authorities and partner institutions for transfer into southern white rhino surrogates as part of the species recovery program.
- Stem Cell-Associated Techniques (SCAT) for Northern White Rhino Stem cell-associated techniques that generate primordial germ cell-like cells (PGCLCs) and induced pluripotent stem cell (iPSC) lines from northern white rhino somatic samples, with the long-term objective of producing functional gametes entirely in vitro. Provided to consortium partners for use in species recovery and for downstream embryo production.
- Genome Resource Bank for Northern White Rhino
Quantifiable outcome
- 38 pure Northern White Rhino embryos produced from 21 OPUs in female Fatu since August 2019
- +6 more outcomes
Companies that use BioRescue
Customer profileSegments1 record
Ideal customer profiles2 records
BioRescue technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
BioRescue partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core and supporting.
- Leibniz Institute for Zoo and Wildlife Research (Leibniz-IZW)coreInternational scientific consortium led by Leibniz-IZW, an internationally renowned German research institute of the Forschungsverbund Berlin e.V. and member of the Leibniz Association. Leibniz-IZW leads the project and conducts OPU-IVF procedures, ethical assessment, and overall scientific coordination. Project head: Prof Thomas Hildebrandt.
- Safari Park Dvůr KrálovécoreSafari park in Czech Republic with largest African animal collection in Europe. Coordinates international rescue efforts and provides Northern White Rhino genetic samples. Birthplace of Najin and Fatu. Coordinates scientific efforts and represents the project internationally.
- Avantea (Laboratory of Reproductive Technologies)coreWorld-leading laboratory of advanced technologies for animal reproduction based in Cremona, Italy. Only laboratory in the world to have succeeded in generating viable rhinoceros embryos. Conducts ICSI, embryo culture and cryopreservation. Over 20 years experience in assisted reproduction of livestock.
- Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC)coreOne of world's leading biomedical research institutions based in Berlin-Buch, Germany. Head of Technology Platform 'Pluripotent Stem Cells' (Dr Sebastian Diecke) focuses on generation of functional oocytes derived from pluripotent stem cells. Supports pregnancy confirmation analyses for Northern White Rhino programme.
- University of PaduacoreOne of the oldest universities in the world (800 years), based in Padua, Italy. Department of Comparative Biomedicine and Food Science leads the ethical research pillar of BioRescue through the Ethics Laboratory for Veterinary Medicine, Conservation and Animal Welfare (directed by Prof Barbara de Mori). Developed and extended ETHAS ethical assessment tool.
- University of OsakacoreMajor Japanese university focusing on pluripotent stem cell research for generating functional oocytes and sperm to increase genetic diversity of future Northern White Rhino founding population. Prof Katsuhiko Hayashi leads the Department of Genome Biology research.
- Kyushu UniversitysupportingPrestigious Japanese state university (founded 1911) located in Fukuoka. Department of Stem Cell Biology and Medicine houses the Developmental Stem Cell Biology Laboratory contributing to stem cell research for the Northern White Rhino conservation programme.
- Ol Pejeta ConservancycoreLargest black rhino sanctuary in East Africa, located in Kenya. Home to the last two Northern White Rhinos (Najin and Fatu) and site of all OPU procedures, embryo transfers, and surrogate mother programme. Provides cutting-edge wildlife security including specialised K-9 unit, motion sensor cameras, and dedicated Rhino Protection Unit.
- Kenya Wildlife Service (KWS)coreKenya's principal government institution that conserves and manages wildlife. Provides regulatory oversight, permits for scientific research, and ownership of surrogate southern white rhinos used in the embryo transfer programme.
- Merck KGaAsupportingLeading science and technology company providing laboratory chemicals, reagents, and biotech products for research conducted by BioRescue consortium partners. Present in Germany with Healthcare, Life Science and Performance Materials sectors.
- Wildlife Research and Training Institute (WRTI)supportingKenyan government body established under Wildlife Conservation and Management Act No. 47 of 2013. Mandate to undertake and coordinate wildlife research and training, and to grant permits for all wildlife scientific research. Works in close cooperation with BioRescue team at Ol Pejeta.
- German Conservation and Research Fund e.V. (CRF)supportingGerman non-profit organisation supporting visual documentation that bridges science, ethics, and wildlife conservation. Coordinated the photographic assignment for Jon A Juárez documenting the world's first successful rhino foetus produced by IVF and embryo transfer.
- Colossal BiosciencessupportingColossal Biosciences supports BioRescue in saving the Northern White Rhino. Partnership aims to restore genetic diversity of a future Northern White Rhino population using museum samples (ancient DNA/de-extinction technologies).
Scale indicators9 records
Recent moves6 records
Expansion highlights5 records
BioRescue competitors and assessment
Company assessmentOthers
- International Rhino Foundation: US-based nonprofit dedicated to the conservation of all five rhino species globally. Operates field programs in Africa and Asia and funds rhino-related research. Tangentially related as a funder/advocate in the rhino conservation ecosystem but does not run aART programs comparable to BioRescue.
- Ol Pejeta Conservancy: Kenyan conservancy hosting the last two NWR females and serving as the field operations site for all BioRescue OPU and embryo transfer procedures. Functions as a conservation site partner rather than a competing research entity.
- Leibniz-IZW (Leibniz Institute for Zoo and Wildlife Research): BioRescue's parent institution and lead research partner, with deep expertise in wildlife reproduction management. The Department of Reproduction Management conducts the OPU-IVF work. Strong operational overlap but functions as the host institution rather than a competing entity.
- Avantea Srl. Italian laboratory of advanced reproductive technologies and core BioRescue consortium partner. The only laboratory globally to have generated viable rhinoceros embryos. Functions as a key technology partner/service provider to the BioRescue program rather than a direct competitor.
Emerging players
- Revive & Restore: US nonprofit advancing genetic rescue and de-extinction for endangered and extinct species, with projects spanning coral, mammals, and birds. Comparable to BioRescue in applying advanced biotechnologies (cloning, stem cells, genomics) to conservation, though broader in taxonomic scope.
Broad incumbents
- San Diego Zoo Wildlife Alliance: Operates the Frozen Zoo, the world's largest cryopreserved wildlife biorepository (>10,000 samples), and runs active ART and biobanking programs for endangered species. A large, established conservation organisation with overlapping aART and biobanking capabilities, though focused across many species rather than the rhino niche.
- Smithsonian's National Zoo and Conservation Biology Institute (SCBI): Major US conservation research institution with active programs in wildlife reproduction, cryopreservation, and biobanking for endangered species including giant pandas and Asian elephants. Comparable in scientific scope and conservation ART application, with a broader species portfolio.
Direct peers
- Colossal Biosciences: US-based de-extinction and genetic rescue company using ancient DNA and CRISPR to restore extinct and endangered species. Direct BioRescue partner supporting NWR genetic restoration, with overlapping mission in reviving lost genetic diversity through advanced reproductive and stem cell technologies.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
BioRescue social profiles
Digital presenceBioRescue financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioRescue leadership team
Management profileNumber of profiles
Profiles10 records
BioRescue funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioRescue M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioRescue
What does BioRescue do?
BioRescue is a research consortium that develops and deploys advanced assisted reproduction technologies (aART) — including ovum pick-up, in-vitro fertilization, intra-cytoplasmic sperm injection, and embryo transfer — together with stem cell-associated techniques (SCAT) such as PGCLC induction, to generate viable Northern White Rhino embryos and eventually restore the subspecies. Its outputs include embryo production for transfer into surrogate southern white rhinos, a genome resource bank of cryopreserved biological material, and ethical frameworks (ETHAS) for guiding conservation biobanking decisions.
Is BioRescue a public or private company?
BioRescue is a private company. It is classified as state government owned and is currently operating.
When was BioRescue founded?
BioRescue was founded in 2019.
Where is BioRescue based?
BioRescue is headquartered in Berlin, Germany, in the Europe region.
Who are BioRescue's main competitors?
Others on record are International Rhino Foundation, Ol Pejeta Conservancy, Leibniz-IZW (Leibniz Institute for Zoo and Wildlife Research) and Avantea Srl.. Revive & Restore is listed as an emerging player. Broad incumbents are San Diego Zoo Wildlife Alliance and Smithsonian's National Zoo and Conservation Biology Institute (SCBI). Colossal Biosciences is listed as a direct peer.
Does BioRescue have an API?
No public API is recorded for BioRescue.
What industry is BioRescue in?
BioRescue's product category is Wildlife Conservation Biotechnology. Its primary akta.pro industry code is HLAMANAD, Cell & Gene Therapy for Veterinary Regeneration, with a secondary code of HLAMANAJ, Cryopreservation, Biobanking & Cell Banking (Cord/Adipose/MSC). Its NAICS code is 541714 and its SIC code is 8731.